Takeda Pharmaceutical TAK
NYSE TAK
$18.21 -0.13 (-0.71%)
At close: Aug 20, 2026 · 12:58 PM UTC

Takeda Pharmaceutical (TAK) FCF Payout Ratio Growth (1y) (2019 - 2026)

Takeda Pharmaceutical (TAK) FCF Payout Ratio Growth (1y) (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Cover Growth (1y) (Qtr)
1 Haleon 43.96 Bn 43.00 Bn - -
2 Teva Pharmaceutical Industries 43.23 Bn 39.58 Bn 2.15 Bn -
3 Zoetis 31.76 Bn 30.08 Bn 1.05 Bn -14.68%
4 Takeda Pharmaceutical 28.68 Bn 22.88 Bn 5.10 Bn -49.97%
5 United Therapeutics 22.27 Bn 19.61 Bn 683.80 Mn -
6 Viatris 18.69 Bn 17.81 Bn 1.46 Bn -49.30%
7 Neurocrine Biosciences 15.56 Bn 15.17 Bn 935.80 Mn -
8 Elanco Animal Health 11.78 Bn 11.25 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.13 Bn 9.97 Bn - -
10 Alkermes 8.14 Bn 7.48 Bn 397.90 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 -49.97%
Mar 31, 2026 -130.26%
Dec 31, 2025 -5.91%
Sep 30, 2025 24.55%
Jun 30, 2025 9.02%
Mar 31, 2025 77.66%
Dec 31, 2024 52.52%
Sep 30, 2024 27.29%
Jun 30, 2024 35.83%
Mar 31, 2024 -279.60%
Dec 31, 2023 -128.00%
Sep 30, 2023 13.93%
Jun 30, 2023 7.34%
Mar 31, 2023 235.87%
Dec 31, 2022 10.72%
Sep 30, 2022 -23.05%
Jun 30, 2022 -51.93%
Mar 31, 2022 30.12%
Dec 31, 2021 35.97%
Sep 30, 2021 -14.45%